Get started

Financials · STXS

Stereotaxis Inc. (STXS) financials

For the twelve months ended Jun 30, 2026, Stereotaxis Inc. reported $30.07M of revenue and -$22.32M of net income.

Revenue, TTM
$30.07M
Revenue growth, YoY
-5.5%
Net income, TTM
-$22.32M
Net margin
-74.2%
Free cash flow, TTM
-$15.50M
EPS, diluted, TTM
-$0.24
Cash
$10.49M
P/S
3.80
Market cap
$114.2M
Annual revenue$32.38M
FY2016FY2025
Annual net income-$21.64M
FY2016FY2025
Annual free cash flow-$13.78M
FY2016FY2025

STXS revenue and earnings growth

STXS revenueQ2 2026$7.67M

Quarter YoY
-12.8%
QoQ
+21.9%
FY YoY
+20.3%
5Y CAGR
+4.0%
10Y CAGR
-1.5%

STXS revenue was $7.67M in fiscal Q2 2026 (ended Jun 30, 2026), down 12.8% from a year earlier and up 21.9% from the prior quarter. For the full fiscal 2025 it was $32.38M, up 20.3% from fiscal 2024. Compound annual growth was +4.0% over 5 years and -1.5% over 10 years. It rose in 3 of the last 10 fiscal years.

STXS net incomeQ2 2026-$4.47M

STXS net income was -$4.47M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$3.83M a year earlier. For the full fiscal 2025 it was -$21.64M, compared with -$24.05M in fiscal 2024.

STXS EPSQ2 2026-$0.05

STXS diluted EPS was -$0.05 in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$0.05 a year earlier. For the full fiscal 2025 it was -$0.25, compared with -$0.30 in fiscal 2024.

STXS free cash flowQ2 2026-$3.74M

STXS free cash flow was -$3.74M in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$13.78M, compared with -$8.53M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$32.38M$26.92M$26.77M$28.15M$35.02M$26.63M$28.90M$29.35M$31.14M$32.16M
Cost of revenue$15.31M$12.32M$11.91M$9.68M$11.79M$7.66M$6.14M$5.72M$10.75M$7.53M
Gross profit$17.07M$14.59M$14.86M$18.47M$23.23M$18.97M$22.77M$23.63M$20.39M$24.63M
Research and development$9.38M$9.76M$10.27M$10.56M$10.20M$8.14M$9.02M$8.22M$6.70M$5.49M
Selling, general and admin$17.85M$17.20M$14.05M$14.36M$13.97M$6.36M$5.84M$4.90M$5.98M$10.35M
Operating income-$22.11M-$24.74M-$21.84M-$18.78M-$12.89M-$6.71M-$4.83M-$2.46M-$5.92M-$6.43M
Interest expense-------$16.6K$179.8K$2.48M
Net income-$21.64M-$24.05M-$20.71M-$18.29M-$10.72M-$6.65M-$4.59M$116.8K-$5.89M-$5.29M
EPS, basic-$0.25-$0.30-$0.27-$0.26-$0.16-$0.11-$0.10-$0.03-$0.32-$0.54
EPS, diluted-$0.25-$0.30-$0.27-$0.26-$0.16-$0.11-$0.10-$0.03-$0.32-$0.54
Diluted shares91.0M85.2M80.7M76.1M75.6M72.7M63.1M52.1M22.6M21.8M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$13.42M$12.22M$19.82M$9.86M$40.14M$43.94M$30.18M$10.80M$3.69M$8.50M
Short-term investments$0$0-$19.84M------
Receivables$5.85M$3.82M$3.82M$5.09M$5.41M$3.52M$5.33M$5.02M$4.29M$4.67M
Inventory$9.57M$8.33M$8.43M$7.88M$4.43M$3.30M$1.85M$1.19M$1.15M$5.38M
Current assets$33.85M$26.44M$33.27M$43.25M$51.39M$52.72M$38.83M$17.97M$9.87M$19.40M
Goodwill$3.76M$3.76M--------
Total assets$52.25M$46.72M$41.91M$53.41M$60.98M$55.46M$43.58M$18.51M$10.67M$20.97M
Current liabilities$22.36M$21.60M$13.25M$14.29M$13.26M$13.57M$12.16M$10.19M$30.13M$35.65M
Short-term debt-----$1.19M----
Long-term debt-----$973.3K----
Total debt-----$2.16M----
Total liabilities$33.53M$35.29M$19.99M$21.48M$21.56M$15.23M$15.06M$11.24M$31.27M$36.50M
Shareholders' equity$13.48M$6.08M$16.34M$26.35M$33.84M$34.63M$22.77M$1.31M-$26.57M-$21.49M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow-$13.69M-$8.50M-$9.14M-$8.41M-$2.95M-$3.51M-$4.62M-$2.55M-$4.67M-$6.56M
Capital expenditures$93.0K$34.0K$366.0K$2.38M$1.40M$70.9K$29.5K$265.5K$81.6K$410.2K
Free cash flow-$13.78M-$8.53M-$9.51M-$10.79M-$4.34M-$3.58M-$4.65M-$2.81M-$4.76M-$6.97M
Investing cash flow-$93.0K$74.0K$19.77M-$22.09M-$1.40M-$70.9K-$29.5K-$265.5K-$81.6K-$410.2K
Financing cash flow$14.76M$297.0K$81.0K$220.0K$547.0K$17.34M$24.03M$9.92M-$58.9K$9.88M
Dividends paid$0$0$0$0$0$0--$0$0
Stock-based compensation$9.85M$10.26M$10.62M$10.58M$9.36M$3.17M$1.33M$561.0K$768.7K$1.37M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY20.3%0.5%-4.9%-19.6%31.5%-7.9%-1.5%-5.8%-3.2%-14.6%
Gross margin52.7%54.2%55.5%65.6%66.3%71.2%78.8%80.5%65.5%76.6%
Operating margin-68.3%-91.9%-81.6%-66.7%-36.8%-25.2%-16.7%-8.4%-19.0%-20.0%
Net margin-66.8%-89.3%-77.4%-65.0%-30.6%-25.0%-15.9%0.4%-18.9%-16.4%
Free cash flow margin-42.6%-31.7%-35.5%-38.3%-12.4%-13.5%-16.1%-9.6%-15.3%-21.7%
Return on equity-160.5%-395.5%-126.7%-69.4%-31.7%-19.2%-20.2%8.9%--
Return on assets-41.4%-51.5%-49.4%-34.2%-17.6%-12.0%-10.5%0.6%-55.2%-25.2%
Current ratio1.511.222.513.033.873.883.191.760.330.54
Debt to equity-----0.06----

Source: XBRL data Stereotaxis Inc. files with the SEC, latest filing dated Aug 12, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

STXS peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
STXS$30.07M-5.5%-$22.32M-74.2%$114.2M
MDT$37.54B+9.8%$5.24B14.0%$131.48B
LIVN$1.51B+11.7%$196.06M13.0%$5.10B
ITGR$1.83B-0.3%$103.70M5.7%$4.30B
TMDX$727.65M+28.5%$144.45M19.9%$3.26B
AXGN$266.93M+24.3%-$31.92M-12.0%$3.02B
CNMD$1.37B+1.6%$73.43M5.4%$1.55B
CBLL$108.72M+31.3%-$73.88M-68.0%$1.07B
INMD$370.50M-6.2%$93.83M25.3%$776.6M

STXS FAQ

9 questions
  • What is STXS revenue?
    Stereotaxis Inc. (STXS) reported $30.07M of revenue for the twelve months ended Jun 30, 2026. That is down 5.5% from the year before. Revenue for fiscal 2025 was $32.38M.
  • Is STXS profitable?
    No. Stereotaxis Inc. reported a net loss of $22.32M for the twelve months ended Jun 30, 2026.
  • How much cash and debt does STXS have?
    Stereotaxis Inc. reported $10.49M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • How fast is STXS revenue growing?
    Stereotaxis Inc.'s revenue changed +20.3% in fiscal 2025, to $32.38M. Its compound annual growth rate was +4.0% over 5 years and -1.5% over 10 years.
  • What is STXS gross margin?
    Stereotaxis Inc.'s gross profit was $16.71M on $30.07M of revenue for the twelve months ended Jun 30, 2026, a gross margin of 55.6%.
  • What is STXS free cash flow?
    Stereotaxis Inc. generated -$15.50M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of -$15.29M less capital expenditures.
  • What is STXS earnings per share?
    Diluted earnings per share were -$0.24 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did STXS last report financial results?
    The latest statements here come from Stereotaxis Inc.'s 10-Q filed on Aug 12, 2026, covering the period ended Jun 30, 2026.
  • Where does this STXS financial data come from?
    Quantisnow builds these statements from the structured XBRL data Stereotaxis Inc. files with the SEC. It is provided for information only and is not investment advice.